| CPC C12P 7/44 (2013.01) [C12N 9/0069 (2013.01); C12N 9/1022 (2013.01); C12N 9/1085 (2013.01); C12N 9/88 (2013.01); C12N 9/90 (2013.01); C12N 15/52 (2013.01); C12N 15/77 (2013.01); C12Y 113/11001 (2013.01); C12Y 202/01001 (2013.01); C12Y 401/01061 (2013.01); C12Y 401/01063 (2013.01); C12Y 402/0101 (2013.01); C12Y 402/03004 (2013.01)] | 5 Claims |
|
1. A genetically engineered bacterium utilizing glucose for de novo synthesis of cis, cis-muconic acid, wherein
the genetically engineered bacterium is Corynebacterium glutamicum ATCC13032 recombinantly modified to comprise a cis,cis-muconic acid pathway construction module and an intermediate high-yield module and further having knockouts of pyk, aroE, pcaG/H and CatB genes; wherein
the cis,cis-muconic acid pathway construction module comprises a protocatechuate decarboxylase gene comprising SEQ ID NO: 37, an UbiX-like flavin prenyltransferase gene comprising SEQ ID NO: 68 or SEQ ID NO: 38, a 4-hydroxybenzoate decarboxylase subunit D gene comprising SEQ ID NO: 69 or SEQ ID NO: 39, and a catechol 1,2-dioxygenase gene comprising SEQ ID NO: 76 or SEQ ID NO: 35; and
the intermediate high-yield module comprises a 3-dehydroquinate synthase gene comprising SEQ ID NO: 51, a 3-dehydroquinate dehydratase gene comprising SEQ ID NO: 52, and a transketolase gene comprising SEQ ID NO: 53.
|